2Dandona P,Aljada A,Mohanty P,et al.Insulin inhibits intranuclear nuclear factor kB and stimulates IkB in mononuclear cells in obese subjects:evidence for an anti-inflamation effect ?[J].J Clin Endocrinol Metab,2001,86:3257-3265
3Festa AD,Agostino R Jr,Howard G,et al.Chronic subclinical inflammation as part of the insulin resistance syndrome[J].Circulation,2000,102:42-27
4McLaughlin T,Abbasi F,Lamendola C,et al.Differentiation between obesity and insulin resistance in the association with Creactive protein[J].Circulation,2002,106:2908-2912
5Tarkun I,Arslan BC,Canturk Z,et al.Endothelial Dysfunction in Young Woman With Polycystic Ovary Syndrome:Relationship With Insulin Resistance and Low-Grade Chronid Inflammation[J].The journal of Clinical Endocrinology & Metabolism,2004,89(11):5592-5596
6Boulman N,Lery Y,Leiba R,et al.Increased C-reactive Protein Levels in the Polycystic ovary syndrome:a marker of cardiovascular disease[J].J Clin Endocrinol Metab,2004,89 (5):2160 -2165
7Orio F Jr,Palomba S,Cascella T,et al.The increase of leukocytes as a new putative marker of Low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome[J].J Clin Endocrinol Metab,2005,90(1):2-5
8Escobar-Morreale HF,Villuendas G,Botella-Carretero JI,et al.Obesity,and not insulin resistance,is the major determinant of serum inflammatory cardiovascular risk markers in premenopausal woman[J].Diabetologia,2003,46 (5):625-633
9Bahceci M,Tuzcu A,Canoruc N,et al.Serum C-reactive Protein (CRP) Levels and insulin resistance in non-obese woman with polycystic ovarian syndrome,and effect of bicalutamide on hirsutism,CRP Levels and insulin resistance[J].Horm Res,2004,62(6):283-287
2Bastard JP,Pieroni L,Hainque B.Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance.Diabetes Metab Res Rev,2000,16:192-201.
3Pandolfi A,Giaccari A,Cilli C,et al.Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat.Acta Diabetol,2001,38:71-76.
4Samad F,Pandey M,Bell PA,et al.Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin- resistant mice and adipocytes.Mol Med,2000,6:680-692.
5Seli E,Duleba A J.Should patients with polycystic ovarian syndrome be treated with metformin.Hum Reprod,2002,17:2230-2236.
6Zuccollo A,Navarro M,Frontera M,et al.The involvement of kallikrein-kinin system in diabetes type Ⅰ (insulitis).Immunopharmacol,1999,45:69-74.
7Vambergue A,Rugeri L,Gaveriaux V,et al.Factor Ⅶ,tissue factor pathway inhibitor,and monocyte tissue factor in diabetes mellitus: influence of type of diabetes,obesity index,and age.Thromb Res,2001,101:367-375.
8Chadarevian R,Bruckert E,Dejager S,et al.Relationship between triglycerides and factor Ⅶc and plasminogen activator inhibitor type-1:lack of threshold value. Thromb Res,1999,96:175-182.
9Davi G,Ciabattoni G,Consoli A,et al.In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.Circulation,1999,99:224-229.
10Limb GA,Webster L,Soomro H,et al.Platelet expression of tumour necrosis factor-alpha (TNF-alpha),TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy.Clin Exp Immunol,1999,118:213-218.
3Lystedt E, Westergren H, Brynhildsen J, et al. Subcutaneous adipocytes from obese hyperinsulinemic women with polycystic ovary syndrome exhibit normal insulin sensitivity but reduced maximal insulin responsiveness. EurJ Endocrinol, 2005,153(6) :831-835.
4Rabelo Acevedo M, Vick MR. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico. P R Health Sci J, 2005,24(3) :203-226.
6Penge S, Yilmaz G, Yilmaz N, et al. Determination of plasma fibronectin and serum C-reactive protein in patients with cerebrovascular events. Int J Clin Pract, 2003,57(2) :91-95.
7Lee WY, Park JS, Noh SY, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP ]H report. Int J Cardiol, 2004,97 ( 1 ) : 101-106.
8Hattori Y, Matsumura M, Kasai K. Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res, 2003,58 ( 1 ) : 186-195.
9Campos SP, Baumann H. Insulin is a prominent modulator of the eytokine-stimulated expression of acute-phase plasma protein genes. Mol Cell Biol, 1992,12(4) : 1789-1797.
10Genazzani AD, Battaglia C, Malavasi B, et al. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Fertll Steril, 2004,81 (1) :114-119.
